Lorimar Ramirez Pagán, MD
- Cancer and Blood Disorders
Associate Professor, Department of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine
Departments:
Office location:
17600 Interstate 45 South
The Woodlands, TX 77384
Get to know Lorimar Ramirez Pagán, MD
Lorimar Ramírez Pagán, MD, is a board-certified Pediatric Hematologist Oncologist at Texas Children’s Hospital The Woodlands with over 13 years of experience. She strives to provide evidence-based care for patients with solid tumors, leukemia/lymphoma, and hematologic disorders as she herself is a pediatric leukemia survivor. She also has extensive experience long term cancer survivorship care, oncofertility, and pain management. Dr. Ramírez Pagán earned her medical degree from University of Puerto Rico Medical Sciences Campus, she completed pediatrics residency at University Pediatric Hospital associated with University of Puerto Rico Medical Sciences Campus, and her pediatric hematology oncology fellowship at MD Anderson Cancer Center in Houston, TX. Outside of the clinic, Dr. Ramírez Pagán enjoys traveling to experience cultural immersion and establish meaningful connections.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| The University of Texas - MD Anderson Cancer Center | Fellowship | Pediatric Hematology-Oncology | 2012 |
| University of Puerto Rico - School of Medicine | Residency | Pediatrics | 2008 |
| University of Puerto Rico - School of Medicine | Internship | Pediatrics | 2006 |
| University of Puerto Rico - School of Medicine | Medical School | Doctor of Medicine | 2005 |
| University of Puerto Rico - Rio Piedras Campus | Bachelors | Bachelor of Science, Biology | 2001 |
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics | Member |
| American Society of Hematology | Member |
| The American Society of Pediatric Hematology/Oncology | Member |
Board Certifications
| Title |
|---|
| American Board of Pediatrics - Pediatrics |
| American Board of Pediatrics - Pediatric Hematology-Oncology |
Honors and awards
- 2011
-
Abstract Achievement Award, HDAC and LSD1 Inhibitors Synergize to Induce Cell Death in Acute Leukemia Cells, 53RD ASH Annual Meeting
- 1998
-
Dean's List, University of Puerto Rico
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Eckstein OS, Visser J, RodriguezGalindo C, Allen CE. Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition. Blood, 133, (15):16911694, Feb 2019. PMID 30718231, PMC6460419.